Mouse Anti-MEP1A Recombinant Antibody (CBYC-P103) (CBMAB-P0503-YC)

Li, M., Huang, C., Wu, Y., Zhu, L., Zhang, Y., Zhou, Y., ... & Liao, W. (2023). Long non-coding RNA CCL14-AS suppresses invasiveness and lymph node metastasis of colorectal cancer cells by regulating MEP1A. Cancer Cell International, 23(1), 1-15.

Ge, W., Hou, C., Zhang, W., Guo, X., Gao, P., Song, X., ... & Wang, J. (2021). Mep1a contributes to Ang II-induced cardiac remodeling by promoting cardiac hypertrophy, fibrosis and inflammation. Journal of molecular and cellular cardiology, 152, 52-68.

Grainger, A. T., Pilar, N., Li, J., Chen, M. H., Abramson, A. M., Becker-Pauly, C., & Shi, W. (2021). Identification of Mep1a as a susceptibility gene for atherosclerosis in mice. Genetics, 219(4), iyab160.

Gao, R., Liu, D., Guo, W., Ge, W., Fan, T., Li, B., ... & Wang, J. (2020). Meprin‐α (Mep1A) enhances TNF‐α secretion by mast cells and aggravates abdominal aortic aneurysms. British journal of pharmacology, 177(12), 2872-2885.

Chen, Y., Wu, F., Zhang, L., Du, L., & Yan, X. (2020). Predictive value of MEP1A in cancer prognosis: A protocol for systematic review and meta-analysis. Medicine, 99(45).

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols